Fler resultat...
Results from a major international study are raising hopes for one of the biggest breakthroughs in pancreatic cancer in decades.
For many people with pancreatic cancer, surgery is not an option at the time of diagnosis. But that doesn’t mean treatment stops—it means the treatment strategy changes.
Christina Gerde speaks on behalf of those who cannot speak for themselves, those living with pancreatic cancer, and those who have lost loved ones to the disease. She was diagnosed three years ago and shares the reality of a disease where relapse is common and treatment options remain limited.
Biotech company Alligator Bioscience AB interviews PALEMA in its annual report for 2025 and discusses, among other things, Emergency cancer (Blåljuscancer), medical needs, clinical studies and what message PALEMA wants to send to decision-makers and healthcare.
This exciting step forward follows a two-year clinical trial, in which researchers at Imperial College London analyzed over 700 breath samples from people with and without pancreatic cancer, as well as from people with other conditions affecting the pancreas.
An 18th century remedy could be a new weapon in the fight against one of the most deadly cancers. Researchers in Skövde, Sweden, together with Skaraborg Hospital, are now starting a clinical trial to investigate whether the heart medicine digitoxin, originally extracted from the foxglove flower, can be used against pancreatic cancer.
Pancreatic cancer is one of the most aggressive cancers. A new study from Karolinska Institutet in collaboration with the Department of Pathology at Karolinska University Hospital shows that tumor cells grow not only in the connective tissue-rich environment typical of the disease, but also in damaged parts of the pancreas where normal tissue has been altered. The findings may provide new insights into tumor development and treatment.
Pancreatic Cancer Europe recently interviewed Christina Gerde, patient representative and member of the Pancreatic Cancer Diagnosis Working Group at PALEMA. In her powerful message, Christina reminds us. More needs to be done for pancreatic cancer for survival rates to go up. The time for that is now.
Pancreatic cancer is one of the most difficult cancers to treat, but several promising studies presented at ASCO 2025 show progress in locally advanced, resectable and metastatic disease.
Pancreatic cancer strikes quickly and mercilessly. Luciano Pavarotti, Ruth Bader Ginsburg, Sven-Göran Eriksson, Johannes Brost. The names are many, the fates tragic. The diagnosis is a death sentence. But now there is hope.
To improve outcomes for people with pancreatic cancer, Pancreatic Cancer UK is investing in research that will help us detect early, treat better and ultimately save lives.
For those who have or will have a duodenal stent, read more about this – including how to manage your diet – in a fact sheet from Pancreatic Cancer UK.
An international research study has shown that pancreatic cancer cells are able to alter the fuel they use to grow and spread to help them survive in difficult environments, a finding that scientists hope could be exploited to develop new treatments for pancreatic cancer.
An artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records.
